Another four lots of a diabetes drug recalled for having too much of a carcinogen
Published Date: 11/3/2020
Source: news.yahoo.com
Nostrum Laboratories announced Monday evening and Tuesday morning that four lots of its version of Type 2 diabetes drug metformin have too much of the carcinogen NDMA.